Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice

Journal of Infectious Diseases

Volumn 194, Issue 8, 2006, Pages 1176-1183

  Ismael, Alaa Bassuny ^a,b   Dimier Poisson, Isabelle ^a,b   Lebrun, Maryse ^c   Dubremetz, Jean François ^c   Bout, Daniel ^a,b   Mévélec, Marie Noëlle ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b CEMAGREF   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN MIC1; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN TISSUE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS CELL; GENE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; MALE; MIC1 GENE; MIC3 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL GENETICS; SURVIVAL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINE PRODUCTION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; VACCINATION;

EID: 33749601621     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507706     Document Type: Article

References (27)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76.
2. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol 2004; 34:423-32.
3. Petersen E, Pollak A, Reiter-Owona I. Recent trends in research on congenital toxoplasmosis. Int J Parasitol 2001; 31:115-44.
4. Buxton D, Thomson K, Maley S, Wright S, Bos HJ. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet Rec 1991; 129:89-93.
5. Fox BA, Bzik DJ. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 2002; 415:926-9.
6. Ménard R. Gliding motility and cell invasion by Apicomplexa: insights from the Plasmodium sporozoite. Cell Microbiol 2001; 3:63-73.
7. Soldati D, Dubremetz JF, Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol 2001; 31:1293-302.
8. Fourmaux MN, Achbarou A, Mercereau-Puijalon O, et al. The MIC1 microneme protein of Toxoplasma gondii contains a duplicated receptor-like domain and binds to host cell surface. Mol Biochem Parasitol 1996; 83:201-10.
9. Garcia-Réguet N, Lebrun M, Fourmaux MN, et al. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell Microbiol 2000; 2:353-64.
10. Lourenço EV, Pereira SR, Faça VM, et al. Toxoplasma gondii micronemal protein MIC1 is a lactose-binding lectin. Glycobiology 2001; 11:541-7.
11. Cérède O, Dubremetz JF, Bout D, Lebrun M. The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin. EMBO J 2002; 21:2526-36.
12. Reiss M, Viebig N, Brecht S, et al. Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. J Cell Biol 2001; 152:563-78.
13. Cérède O, Dubremetz JF, Soête M, et al. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J Exp Med 2005; 201:453-63.
14. Ismael AB, Sekkai D, Collin C, Bout D, Mévélec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003; 71:6222-8.
15. Ajzenberg D, Congé N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186:684-9.
16. Owen MR, Trees AJ. Genotyping of Toxoplasma gondii associated with abortion in sheep. J Parasitol 1999; 85:382-4.
17. Shirahata T, Muroya N, Ohta C, Goto H, Nakane A. Correlation between increased susceptibility to primary Toxoplasma gondii infection and depressed production of gamma interferon in pregnant mice. Microbiol Immunol 1992; 36:81-91.
18. Thouvenin M, Candolfi E, Villard O, Klein JP, Kien T. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent. Parassitologia 1997; 39:279-83.
19. Luft BJ, Remington JS. Effect of pregnancy on resistance to Listeria moncytogenes and Toxoplasma gondii infections in mice. Infect Immun 1982; 38:1164-71.
20. Shirahata T, Muroya N, Ohta C, Goto H, Nakane A. Enhancement by recombinant human interleukin 2 of host resistance to Toxoplasma gondii infection in pregnant mice. Microbiol Immunol 1993; 37:583-90.
21. Alexander J, Jebbari H, Bluethmann H, Brombacher F, Roberts CW. The role of IL-4 in adult acquired and congenital toxoplasmosis. Int J Parasitol 1998; 28:113-20.
22. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mosmann TR. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions: correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J Immunol 1996; 156:653-62.
23. Long MT, Baszler TV. Neutralization of maternal IL-4 modulates congenital protozoal transmission: comparison of innate versus acquired immune responses. J Immunol 2000; 164:4768-74.
24. Pettersen EK. Transmission of toxoplasmosis via milk from lactating mice. Acta Pathol Microbiol Immunol Scand [B] 1984; 92:175-6.
25. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2001; 31:1217-58
26. [erratum: Int J Parasitol 2001; 21:217-20].
27. Dubey JP. Re-examination of resistance of Toxoplasma gondii tachyzoites and bradyzoites to pepsin and trypsin digestion. J Parasitol 1998; 116:43-50.